PGLYRP1 and neoplasm: On the one hand, they are responsible for autoimmune disorders that involve inflammation and tissue injury; on the other hand, they can kill tumor cells in the same way as do TNFα and the Tag7–Hsp70 complex, thereby showing an antitumor activity.